The Hospital-Acquired Infections (HAI) therapeutics market is booming, projected to reach $28 billion by 2033. Learn about market trends, key players (Merck, Pfizer, etc.), and regional growth in this comprehensive analysis of antibacterial, antiviral, and antifungal drugs used to treat HAIs like UTI, VAP, and SSI.
We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.
